Stellular Bio Announces Closing of Series 1 Financing
PR Newswire —
Investment intended to fuel advancement of novel Platelet-derived Regenerative Biologic therapy for Sjogren's disease dry eye and other ocular surface diseases WATERTOWN, Mass., Jan. 28, 2026 /PRNewswire/ -- Stellular Bio, the pioneer of Platelet-derived Regenerative Biologic (PRB)...